Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.
暂无分享，去创建一个
M. Piccart | J. Verweij | A. Sparreboom | A. Awada | M. D. de Jonge | G. Luyten | D. Cutler | P. Statkevich | M. D. Jonge | F. Eskens | A. Hanauske | M. Faber | Ahmad Awada | David L. Cutler | Gré P.M. Luyten | Jaap Verweij | Axel-R. Hanauske | Martine Piccart | A. Hanauske